Evidence map›Paper›PMID 24932939›Full record

ArticleNeurobiology of disease2014

Maternal choline supplementation improves spatial mapping and increases basal forebrain cholinergic neuron number and size in aged Ts65Dn mice.

Jessica A Ash, Ramon Velazquez, Christy M Kelley, Brian E Powers, Stephen D Ginsberg, Elliott J Mufson, Barbara J Strupp

Open access · greenAbstract read
In one paragraph

Article in Neurobiology of disease, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed, 2 pooled it
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 2 syntheses or guidelines pooled it, 83 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Prenatal choline supplementation improves child sustained attention: A 7-year follow-up of a randomized controlled feeding trial.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2022
    Trial
  4. Trial
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Resistance and resilience to Alzheimer's disease in Down syndrome.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Jessica A AshDivision of Nutritional Sciences, Cornell University, Ithaca, NY 14853, USA.
Ramon VelazquezDepartment of Psychology, Cornell University, Ithaca, NY 14853, USA.
Christy M KelleyDivision of Nutritional Sciences, Cornell University, Ithaca, NY 14853, USA.
Brian E PowersDivision of Nutritional Sciences, Cornell University, Ithaca, NY 14853, USA.
Stephen D GinsbergCenter for Dementia Research, Nathan Kline Institute, Orangeburg, NY, USA; Departments of Psychiatry and Physiology & Neuroscience, New York University Langone Medical Center, New York, NY 10962, USA.
Elliott J MufsonDepartment of Neurological Sciences, Rush University Medical Center, Chicago, IL 60612, USA.
Barbara J StruppDivision of Nutritional Sciences, Cornell University, Ithaca, NY 14853, USA; Department of Psychology, Cornell University, Ithaca, NY 14853, USA. Electronic address: bjs13@cornell.edu.
Cornell University · USNYU Langone Health · USRush University Medical Center · US

Funding

Uncovering Alzheimer's disease risk mechanisms through neuron-specific analysis of autophagy and endosomal-lysosomal functionP01AG017617 · NIA · NATHAN S. KLINE INSTITUTE FOR PSYCH RES · PI NIXON, RALPH A. · 2000 to 2021
$40.0M
TAU, AB, SYNUCLEIN AND NITRATIVE/OXIDATIVE DAMAGE IN MCIP01AG014449 · NIA · UNIVERSITY OF PITTSBURGH · PI IKONOMOVIC, MILOS D · 1997 to 2024
$39.7M
Cellular and Molecular Medial Temporal Lobe Pathology in Elderly PreMCI subjectsR01AG043375 · NIA · ST. JOSEPH'S HOSPITAL AND MEDICAL CENTER · PI GINSBERG, STEPHEN D, MUFSON, ELLIOTT JAY · 2013 to 2017
$3.6M
Perinatal choline therapy in a mouse model of Down Syndrome & Alzheimer's DiseaseR01HD057564 · NICHD · CORNELL UNIVERSITY · PI STRUPP, BARBARA J · 2008 to 2012
$2.9M
Genetics, Neurobiology, and Cognition in Down SyndromeR01HD045224 · NICHD · UNIVERSITY OF COLORADO DENVER · PI MACLEAN, KENNETH N · 2003 to 2007
$1.5M
NIA NIH HHS AG014449NIA NIH HHS AG043375NIA NIH HHS P01 AG014449NIA NIH HHS P01 AG017617NIA NIH HHS R01 AG043375NICHD NIH HHS HD057564NICHD NIH HHS HD45224NICHD NIH HHS R01 HD045224NICHD NIH HHS R01 HD057564
6 · The paper itself

Abstract

Down syndrome (DS) is marked by intellectual disability (ID) and early-onset of Alzheimer's disease (AD) neuropathology, including basal forebrain cholinergic neuron (BFCN) degeneration. The present study tested the hypothesis that maternal choline supplementation (MCS) improves spatial mapping and protects against BFCN degeneration in the Ts65Dn mouse model of DS and AD. During pregnancy and lactation, dams were assigned to either a choline sufficient (1.1g/kg choline chloride) or choline supplemented (5.0g/kg choline chloride) diet. Between 13 and 17months of age, offspring were tested in the radial arm water maze (RAWM) to examine spatial mapping followed by unbiased quantitative morphometry of BFCNs. Spatial mapping was significantly impaired in unsupplemented Ts65Dn mice relative to normal disomic (2N) littermates. Additionally, a significantly lower number and density of medial septum (MS) hippocampal projection BFCNs was also found in unsupplemented Ts65Dn mice. Notably, MCS significantly improved spatial mapping and increased number, density, and size of MS BFCNs in Ts65Dn offspring. Moreover, the density and number of MS BFCNs correlated significantly with spatial memory proficiency, providing support for a functional relationship between these behavioral and morphometric effects of MCS for trisomic offspring. Thus, increasing maternal choline intake during pregnancy may represent a safe and effective treatment approach for expectant mothers carrying a DS fetus, as well as a possible means of BFCN neuroprotection during aging for the population at large.

Indexed as

Maternal Nutritional Physiological PhenomenaAgingAnimalsBasal ForebrainCell CountCell SizeCholineCholinergic NeuronsDietary SupplementsDisease Models, AnimalDown SyndromeFemaleLactationMaleMaze LearningMice, TransgenicCholineAlzheimer's diseaseDown syndromeHippocampusMedial septumNucleus basalisRadial arm water mazeSpatial memoryStereologyVertical limb of the diagonal band

Identifiers

PMID24932939
PMCPMC4133151
OpenAlexW1992185194

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.